Dimensional Fund Advisors LP Contrafect Corp Transaction History

Dimensional Fund Advisors LP

  • $376 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$2.79 - $4.45 $51,210 - $81,679
18,355 Added 16.27%
131,137 $402,000
Q1 2022

May 13, 2022
BUY
$2.26 - $3.84 $98,454 - $167,285
43,564 Added 62.94%
112,782 $412,000
Q4 2021

Feb 09, 2022
BUY
$2.47 - $4.14 $118,601 - $198,790
48,017 Added 226.48%
69,218 $182,000
Q3 2021

Nov 12, 2021
BUY
$3.19 - $4.43 $67,631 - $93,920
21,201 New
21,201 $86,000

Others Institutions Holding CFRX

# of Institutions
2
Shares Held
49.2K
Call Options Held
0
Put Options Held
0
View Full List

About CONTRAFECT Corp

CFRX Quotes by TradingView
  • Ticker CFRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,332,700
  • Market Cap $1.18M
  • Description
  • ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus...
More about CFRX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email